Jeremy M Palmer
Overview
Explore the profile of Jeremy M Palmer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
OBoyle G, Fox C, Walden H, Willet J, Mavin E, Hine D, et al.
Proc Natl Acad Sci U S A
. 2012 Mar;
109(12):4598-603.
PMID: 22392992
The recruitment of T lymphocytes during diseases such as rheumatoid arthritis is regulated by stimulation of the chemokine receptors expressed by these cells. This study was designed to assess the...
12.
Walden H, Kirby J, Yeaman S, Gray J, Jones D, Palmer J
Hepatology
. 2008 Nov;
48(6):1874-84.
PMID: 19003917
Unlabelled: Lipoylated enzymes such as the E2 component of pyruvate dehydrogenase complex (PDC-E2) are targets for autoreactive immune responses in primary biliary cirrhosis, with lipoic acid itself forming a component...
13.
Jones D, Palmer J, Burt A, Kirby J
Hepatology
. 2008 Sep;
48(4):1353-4.
PMID: 18792128
No abstract available.
14.
Hollingsworth K, Newton J, Taylor R, McDonald C, Palmer J, Blamire A, et al.
Clin Gastroenterol Hepatol
. 2008 Aug;
6(9):1041-8.
PMID: 18691944
Background & Aims: Primary biliary cirrhosis (PBC) is characterized in 95% of patients by autoantibody responses directed against the mitochondrial antigen pyruvate dehydrogenase complex (PDC). Although anti-PDC inhibits PDC function...
15.
McHugh A, Robe A, Palmer J, Jones D
Liver Int
. 2006 Apr;
26(4):406-13.
PMID: 16629643
Background: Autoantibody responses reactive with the E2 and E3BP components of pyruvate dehydrogenase complex (PDC), which characterise primary biliary cirrhosis (PBC) crossreact, precluding the identification, from serological studies, of the...
16.
Greenall A, Williams E, Martin K, Palmer J, Gray J, Liu C, et al.
J Biol Chem
. 2006 Jan;
281(13):8732-9.
PMID: 16428807
The fission yeast HIRA proteins Hip1 and Slm9 are members of an evolutionarily conserved family of histone chaperones that are implicated in nucleosome assembly. Here we have used single-step affinity...
17.
Robe A, Kirby J, Jones D, Palmer J
Hepatology
. 2005 Apr;
41(5):1106-12.
PMID: 15830397
The key immunological event in the pathogenesis of the autoimmune liver disease primary biliary cirrhosis is breakdown of T-cell self-tolerance to pyruvate dehydrogenase complex (PDC). The mechanism resulting in this...
18.
Palmer J, Robe A, Burt A, Kirby J, Jones D
Hepatology
. 2004 Jun;
39(6):1583-92.
PMID: 15185299
The autoimmune liver disease primary biliary cirrhosis (PBC) is characterized by the breakdown of normal immune self tolerance to pyruvate dehydrogenase complex (PDC). How tolerance is broken to such a...
19.
Wain J, Palmer J, Kirby J, Ali S
J Immunol Methods
. 2003 Sep;
279(1-2):233-49.
PMID: 12969564
Chemokines are a family of small chemoattractant cytokines implicated in the recruitment and migration of leukocytes from the blood into tissues during disease and routine immune homeostasis. Although there are...
20.
Jones D, Palmer J, Robe A, Kirby J
Autoimmunity
. 2003 May;
35(8):537-44.
PMID: 12765480
Primary biliary cirrhosis (PBC) is characterised by immune-mediated damage to the intra-hepatic biliary epithelial cells (BEC). Immuno-modulatory/suppressive therapy represents, therefore, alogical approach to treatment in this disease. Conventional immuno-suppressive and...